SCHEDULE: Intracoastal Capital Discloses 9.99% Stake in SeaStar Medical
Beneficial Ownership Report (Schedule 13G Amendment)
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, has reported a 9.99% beneficial ownership stake in SeaStar Medical Holding Corporation.
Summary
- Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC (collectively, the "Reporting Persons") have filed an Amendment No. 1 to Schedule 13G for SeaStar Medical Holding Corporation.
- As of September 30, 2025, the Reporting Persons beneficially owned an aggregate of 3,098,175 shares of SeaStar Medical Holding Corporation's common stock.
- This beneficial ownership represents approximately 9.99% of the company's common stock.
- The 3,098,175 shares consist of 1,346,154 shares issuable upon exercise of Intracoastal Warrant 1, 1,346,154 shares from Intracoastal Warrant 2, and 405,867 shares from Intracoastal Warrant 3.
- The calculation of the percentage is based on 27,914,596 shares of common stock outstanding as of August 6, 2025, as reported by the Issuer, plus the shares issuable from the aforementioned warrants.
- The filing notes that several other warrants (Intracoastal Warrant 3, 4, 5, and 6) contain blocker provisions that prevent the holder from exercising them to the extent that beneficial ownership would exceed 9.99% (or 4.99% for Warrants 5 and 6).
- Without these blocker provisions, the Reporting Persons would have been deemed to beneficially own 5,342,845 shares of Common Stock.
- The Reporting Persons certified that the securities were not acquired and are not held for the purpose of changing or influencing control of the issuer, other than activities solely in connection with a nomination under Rule 14a-11.
Sentiment
Score: 5
Explanation: This is a factual disclosure of beneficial ownership and does not inherently convey positive or negative sentiment regarding the company's performance or prospects.
Future Outlook
NA
Industry Context
NA
Stakeholder Impact
- Shareholders: The disclosure of a significant 9.99% stake by an investment group could be viewed as a positive signal of institutional interest in SeaStar Medical Holding Corporation, potentially influencing investor sentiment and trading activity.
Key Dates
| Date | Description |
|---|---|
| 2025-08-06 | Date of reported shares outstanding by the Issuer (27,914,596 shares). |
| 2025-09-30 | Date of event which requires the filing of this statement, reflecting the beneficial ownership. |
| 2025-11-07 | Signature date for Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC. |
Keywords
SeaStar Medical Holding Corporation, Intracoastal Capital LLC, Mitchell P. Kopin, Daniel B. Asher, Beneficial Ownership, Schedule 13G, Common Stock, Warrants, Equity Stake
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.